A Trial Comparing Moxifloxacin Versus Levofloxacin Plus Metronidazole In Uncomplicated Pelvic Inflammatory Disease

NCT00453349 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

460

Enrollment

INDUSTRY

Sponsor class

Conditions

Pelvic Inflammatory Disease

Interventions

DRUG: Moxifloxacin (Avelox, BAY12-8039)
DRUG: Levofloxacin & Metronidazole

Sponsor

Bayer